Clinical trial
BAsel Stent Kosten Effektivitäts Trial - SAphenous Venous Graft Angioplasty Using Glycoprotein IIb/IIIa Receptor Inhibitors and Drug-Eluting Stents
NCT00595647 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BAsel Stent Kosten Effektivitäts Trial - SAphenous Venous Graft Angioplasty Using Glycoprotein IIb/IIIa Receptor Inhibitors and Drug-Eluting Stents
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 29, 2008
- Completion date
- March 31, 2014
- Enrollment
- 162 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.